SEARCH

SEARCH BY CITATION

References

  • Ahn J. S., Camden J. M., Schrader A. M., Redman R. S. and Turner J. T. (2000) Reversible regulation of P2Y2 nucleotide receptor expression in the duct-ligated rat submandibular gland. Am. J. Physiol. Cell Physiol. 279, C286C294.
  • Allan S. M. and Rothwell N. J. (2001) Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734744, Review.
  • Allinson T. M., Parkin E. T., Turner A. J. and Hooper N. M. (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res. 74, 342352.
  • Anderson J. P., Refolo L. M., Wallace W. et al. (1989) Differential brain expression of the Alzheimer’s amyloid precursor protein. EMBO J. 8, 36273632.
  • Black R. A., Rauch C. T., Kozlosky C. J. et al. (1997) A metalloproteinase disintegrin that releases tumor-necrosis factor-alpha from cells. Nature 385, 729733.
  • Bogdanov Y. D., Wildman S. S., Clements M. P., King B. F. and Burnstock G. (1998) Molecular cloning and characterization of rat P2Y4 nucleotide receptor. Br. J. Pharmacol. 124, 428430.
  • Brugg B., Dubreuil Y. L., Huber G., Wollman E. E., Delhaye-Bouchaud N. and Mariani J. (1995) Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl Acad. Sci. USA 92, 30323035.
  • Brunschweiger A. and Müller C. E. (2006) P2 receptors activated by uracil nucleotides – an update. Curr. Med. Chem. 13, 289312.
  • Burnstock G. (2000) P2X receptors in sensory neurons. Br. J. Anaesth. 84, 476488.
  • Cacquevel M., Lebeurrier N., Cheenne S. and Vivien D. (2004) Cytokines in neuroinflammation and Alzheimer’s disease. Curr. Drug Targets 5, 529534, Review.
  • Camden J. M., Schrader A. M., Camden R. E., Gonzalez F. A., Erb L., Seye C. I. and Weisman G. A. (2005) P2Y2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing. J. Biol. Chem. 280, 1869618702.
  • Canet-Aviles R. M., Anderton M., Hooper N. M., Turner A. J. and Vaughan P. F. (2002) Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(α), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C. Brain Res. Mol. Brain Res. 102, 6272.
  • Checler F. (1995) Processing of the beta-amyloid precursor protein and its regulation in Alzheimer’s disease. J. Neurochem. 65, 14311444.
  • Cho H. W., Kim J. H., Choi S. and Kim H. J. (2006) Phospholipase A2 is involved in muscarinic receptor-mediated sAPPalpha release independently of cyclooxygenase or lypoxygenase activity in SH-SY5Y cells. Neurosci. Lett. 397, 214218.
  • Ciccarelli R., Ballerini P., Sabatino G., Rathbone M. P., D’Onofrio M., Caciagli F. and Di Iorio P. (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19, 395414.
  • Colangelo V., Schurr J., Ball M. J., Pelaez R. P., Bazan N. G. and Lukiw W. J. (2003) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462473.
  • Desdouits-Magnen J., Desdouits F., Takeda S., Syu L. J., Saltiel A. R., Buxbaum J. D., Czernik A. J., Nairn A. C. and Greengard P. (1998) Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J. Neurochem. 70, 524530.
  • Esler W. P. and Wolfe M. S. (2001) A portrait of Alzheimer secretases – new features and familiar faces. Science 293, 14491454.
  • Fu W., Lu C. and Mattson M. P. (2002) Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J. Neurosci. 22, 1071010719.
  • Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M. and Mattson M. P. (1996) Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 18821896.
  • Griffin W. S., Sheng J. G., Gentleman S. M., Graham D. I., Mrak R. E. and Roberts G. W. (1994) Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci. Lett. 176, 133136.
  • Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J. D. and Wenk G. L. (1998) Chronic neuroinflammation is a contributor to the pathophysiology of Alzheimer’s disease. Brain Res. 780, 294303.
  • Hou M., Moller S., Edvinsson L. and Erlinge D. (2000) Cytokines induced upregulation of vascular P2Y2 receptors and increased mitogenic responses to UTP and ATP. Arterioscler. Thromb. Vasc. Biol. 20, 20642069.
  • Johnson S. A., Pasinetti G. M., May P. C., Ponte P. A., Cordell B. and Finch C. E. (1988) Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp. Neurol. 102, 264268.
  • Kaczmarek E., Erb L., Koziak K., Jarzyna R., Wink M. R., Guckelberger O., Blusztajn J. K., Trinkaus-Randall V., Weisman G. A. and Robson S. C. (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb. Haemost. 93, 735742.
  • Kim J. H. and Kim H. J. (2005) Direct involvement of G protein alpha(q/11) subunit in regulation of muscarinic receptor-mediated sAPPalpha release. Arch. Pharm. Res. 28, 12751281.
  • Kirazov L., Loffler T., Schliebs R. and Bigl V. (1997) Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices. Neurochem. Int. 30, 557563.
  • Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S. and Ito H. (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331, 530532.
  • Koike H., Tomioka S., Sorimachi H. et al. (1999) Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343, 371375.
  • Kojro E. and Fahrenholz F. (2005) The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell. Biochem. 38, 105127.
  • Kong Q., Wang M., Liao Z. et al. (2005) P2X7 nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neurons. Purinergic Signal 1, 337347.
  • Koshiba M., Apasov S., Sverdlov V., Chen P., Erb L., Turner J. T., Weisman G. A. and Sitkovsky M. V. (1997) Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc. Natl Acad. Sci. USA 94, 831836.
  • Lahiri D. K., Lewis S. and Farlow M. R. (1994) Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. J. Neurosci. Res. 37, 777787.
  • Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C. and Fahrenholz F. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Sci. USA 96, 39223927.
  • LeBlanc A. C., Chen H. Y., Autilio-Gambetti L. and Gambetti P. (1991) Differential APP gene expression in rat cerebral cortex, meninges, and primary astroglial, microglial and neuronal cultures. FEBS Lett. 292, 171178.
  • LeBlanc A. C., Xue R. and Gambetti P. (1996) Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J. Neurochem. 66, 23002310.
  • LeBlanc A. C., Papadopoulos M., Belair C., Chu W., Crosato M., Powell J. and Goodyer C. G. (1997) Processing of amyloid precursor protein in human primary neuron and astrocyte cultures. J. Neurochem. 68, 11831190.
  • LeBlanc A. C., Koutroumanis M. and Goodyer C. G. (1998) Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Aβ production in human primary neuron cultures. J. Neurosci. 18, 29072913.
  • Li H. L., Roch J. M., Sundsmo M., Otero D., Sisodia S., Thomas R. and Saitoh T. (1997) Defective neurite extension is caused by a mutation in amyloid beta/A4 (A beta) protein precursor found in familial Alzheimer’s disease. J. Neurobiol. 32, 469480.
  • Li Y., Liu L., Kang J., Sheng J. G., Barger S. W., Mrak R. E. and Griffin W. S. (2000) Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20, 149155.
  • Luo J. J., Wallace M. S., Hawver D. B., Kusiak J. W. and Wallace W. C. (2001) Characterization of the neurotrophic interaction between nerve growth factor and secreted alpha-amyloid precursor protein. J. Neurosci. Res. 63, 410420.
  • Ma G., Chen S., Wang X., Ba M., Yang H. and Lu G. (2005) Short-term interleukin-1(beta) increases the release of secreted APPα via MEK1/2-dependent and JNK-dependent alpha-secretase cleavage in neuroglioma U251 cells. J. Neurosci. Res. 80, 683692.
  • Martins R. N., Robinson P. J., Chleboun J. O., Beyreuther K. and Masters C. L. (1991) The molecular pathology of amyloid deposition in Alzheimer’s disease. Mol. Neurobiol. 5, 389398.
  • Mattson M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 10811132.
  • Mills J. and Reiner P. B. (1999) Regulation of amyloid precursor protein cleavage. J. Neurochem. 72, 433460.
  • Mills J., Laurent Charest D., Lam F., Beyreuther K., Ida N., Pelech S. L. and Reiner P. B. (1997) Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17, 94159422.
  • Moses G. S., Jensen M. D., Lue L. F., Walker D. G., Sun A. Y., Simonyi A. and Sun G. Y. (2006) Secretory PLA2-IIA: a new inflammatory factor for Alzheimer’s disease. J. Neuroinflam. 7, 328.
  • Moss M. L., Jin S. L., Milla M. E. et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733736.
  • Muscella A., Elia M. G., Greco S., Storelli C. and Marsigliante S. (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J. Cell. Physiol. 195, 234240.
  • Nitsch R. M., Slack B. E., Wurtman R. J. and Growdon J. H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304307.
  • Nitsch R. M., Slack B. E., Farber S. A. et al. (1994) Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer’s disease in transfected cell lines and in brain slices. J. Neural Transm. Suppl. 44, 2127.
  • Nitsch R. M., Wurtman R. J. and Growdon J. H. (1995) Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer’s disease. Arzneim Forsch. 45, 435438.
  • Nitsch R. M., Deng A., Wurtman R. J. and Growdon J. H. (1997) Metabotropic glutamate receptor subtype mGluR1alpha stimulates the secretion of the amyloid beta-protein precursor ectodomain. J. Neurochem. 69, 704712.
  • Parihar M. S. and Hemnani T. (2004) Alzheimer’s disease pathogenesis and therapeutic interventions. J. Clin. Neurosci. 11, 456467.
  • Parkin E. T., Trew A., Christie G., Faller A., Mayer R., Turner A. J. and Hooper N. M. (2002) Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha. Biochemistry (Mosc) 41, 49724981.
  • Parvathy S., Hussain I., Karran E. H., Turner A. J. and Hooper N. M. (1998) Alzheimer’s amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry 37, 16801685.
  • Pierce J. W., Schoenleber R., Jesmok G., Best J., Moore S. A., Collins T. and Gerritsen M. E. (1997) Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272, 2109621103.
  • Robert S. J., Zugaza J. L., Fischmeister R., Gardier A. M. and Lezoualc’h F. (2001) The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 276, 4488144888.
  • Rothwell N. J. and Luheshi G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618625.
  • Schrader A. M., Camden J. M. and Weisman G. A. (2005) P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjogren’s syndrome. Arch. Oral Biol. 50, 533540.
  • Seye C. I., Gadeau A. P., Daret D., Dupuch F., Alzieu P., Capron L. and Desgranges C. (1997) Overexpression of the P2Y2 purinoceptor in intimal lesion of the rat aorta. Arterioscler. Thromb. Vasc. Biol. 17, 36023610.
  • Seye C. I., Kong Q., Erb L., Garrad R. C., Krugh B. W., Wang M., Turner J. T., Sturek M., Gonzalez F. A. and Weisman G. A. (2002) Functional P2Y2 nucleotide receptors mediate uridine 5′-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106, 27202726.
  • Shaftel S. S., Carlson T. J., Olschowka J. A., Kyrkanides S., Matousek S. B. and O’Banion M. K. (2007) Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J. Neurosci. 27, 93019309.
  • Sheng J. G., Zhu S. G., Jones R. A., Griffin W. S. and Mrak R. E. (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp. Neurol. 163, 388391.
  • Skaper S. D. (2007) The brain as a target for inflammatory processes and neuroprotective strategies. Ann. NY Acad. Sci. 1122, 2334.
  • Solano D. C., Sironi M., Bonfini C., Solerte S. B., Govoni S. and Racchi M. (2000) Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J. 14, 10151022.
  • Standridge J. B. (2006) Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer’s disease. Curr. Alzheimer Res. 3, 95108.
  • Stein T. D., Anders N. J., DeCarli C., Chan S. L., Mattson M. P. and Johnson J. A. (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J. Neurosci. 24, 77077717.
  • Stella N., Estelles A., Siciliano J., Desagher S., Piomelli D., Glowinski J. and Premont J. (1997) Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes. J. Neurosci. 17, 29392946.
  • Stoll G., Jander S. and Schroeter M. (2002) Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 513, 87113.
  • Sue W. and Griffin T. (2006) Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 83, 470S474S.
  • Tachida Y., Nakagawa K., Saito T. et al. (2008) Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production. J. Neurochem. 104, 13871389.
  • Tanaka S., Shiojiri S., Takahashi Y., Kitaguchi N., Ito H., Kameyama M., Kimura J., Nakamura S. and Ueda K. (1989) Tissue-specific expression of three types of beta-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer’s disease brain. Biochem. Biophys. Res. Commun. 165, 14061414.
  • Turner J. T., Weisman G. A. and Camden J. M. (1997) Upregulation of P2Y2 nucleotide receptors in rat salivary gland cells during short-term culture. Am. J. Physiol. 273, C1100C1107.
  • Turner J. T., Park M., Camden J. M. and Weisman G. A. (1998) Salivary gland nucleotide receptors: changes in expression and activity related to development and tissue damage. Ann. NY Acad. Sci. 842, 7075.
  • Wang M., Kong Q., Gonzalez F. A., Sun G. Y., Erb L., Seye C. I. and Weisman G. A. (2005) P2Y2 nucleotide receptor interaction with αv integrin mediates astrocyte migration. J. Neurochem. 95, 630640.
  • Weisman G. A., Wang M., Kong Q., Chorna N. E., Sun G. Y., Gonzalez F. A., Seye C. I. and Erb L. (2005) Molecular determinants of P2Y2 nucleotide receptor function. Mol. Neurobiol. 31, 169183.
  • Wyss-Coray T., Lin C., Yan F., Yu G. Q., Rohde M., McConlogue L., Masliah E. and Mucke L. (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612618.